Clinical Trials Directory

Trials / Completed

CompletedNCT02217657

SmartTouch Catheter for Left Anterior Line - SmarT Line Study

"Bidirectional Conduction Block of Left Atrial Anterior Line in Patients With Left Atrial Ablation - Reduction of RF Applications Using the Thermocool SmartTouch Contact Force Sensing Catheter

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
LMU Klinikum · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This prospective, randomized study will investigate, if information of the catheter force during ablation of a left anterior line does reduce total RF application time by prevention of ineffective lesions.

Detailed description

Catheter ablation has emerged as a realistic therapeutic option for symptomatic atrial fibrillation (AF). The three main techniques described for ablation of persistent AF include pulmonary vein (PV) isolation, ablation based on electrogram analysis, and left atrial (LA) linear lesions. The ideal endpoint of linear lesions should be complete electrical block; however, this is technically challenging, time consuming, and potentially hazardous. The ST catheter combined with 3D mapping and navigation software, gives physicians a real-time, objective measure of tip-to-tissue contact force during the catheter ablation procedure and will allow physicians to more safely and effectively treat atrial fibrillation.

Conditions

Interventions

TypeNameDescription
DEVICEThermocool Smart Touch CatheterPhysician informed to contact force

Timeline

Start date
2013-08-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2014-08-15
Last updated
2021-02-25

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02217657. Inclusion in this directory is not an endorsement.